Posts by Sandra Ansanay-Alex
Clee Medical Secures Seed Funding to Advance Real-Time Brain Imaging Technology
Clee Medical, a Geneva-based neurotechnology startup, has successfully closed its Seed financing round to accelerate the development of its ultra-high-resolution real-time imaging platform for brain surgery. The round was led by High-Tech Gründerfonds (HTGF), with participation from Zürcher Kantonalbank (ZKB), Kickfund, FONGIT, Venture Kick, and continued support from Wyss Geneva. At the core of the…
Read MoreKYLYS AESTHETICS SA Completes its First Clinical Trial
KYLYS AESTHETICS SA, a University of Geneva spinoff and Swiss clinical-stage biotech company developing next-generation regenerative aesthetic medical devices, announces the successful completion of patient injections in its first clinical trial. A total of 55 patients have now been treated as part of this study evaluating the company’s proprietary hyaluronic acid-based injectable technology. This milestone…
Read MoreSeprify and Grolman Launch SilvaLuma™ in Cosmetics Market
The Fribourg-based company created a cellulose-based ingredient, SilvaLuma™ as an alternative to titanium dioxide for coloring food or cosmetic products.
Read MoreScience Corp. and Neurosoft Bioelectronics Announce Novel BCI Ecosystem Partnership
Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life, and Neurosoft Bioelectronics, a Swiss neural data company utilizing ultra-soft interfaces to achieve full- cortical coverage powering a foundational AI model of the brain, have partnered to grant Neurosoft access to Science’s full stack of world-class clinical-grade neural recording tools, known…
Read MoreCarewell Gets a FIT Digital Growth Loan
Carewell, the Vaud-based digital platform for managing replacement healthcare staff, has been granted a CHF 200,000 Digital Growth Loan from Fondation pour l’Innovation Technologique (FIT). The staff shortage in Switzerland is set to worsen, with an expected shortfall of 40,000 people by 2040. Part of the problem is the process of managing replacement staff. Until…
Read MoreNose Switzerland Gets a FIF Seed Impact Grant
Nose Switzerland is addressing malnutrition in cancer patients with taste and smell disorders. The project got a CHF 20,000 FIF Seed Impact Grant. Developed in close collaboration with researchers from Hôpitaux Universitaires de Genève (HUG) and Université de Genève (UNIGE), Nose Switzerland addresses a pressing but often overlooked consequence of cancer treatment: chemosensory dysfunction. Patients who undergo…
Read MoreTimeline Partners with Lancôme
Swiss biotech Timeline, born at EPFL Innovation Park, has entered a landmark global partnership with Lancôme, the flagship beauty brand of L’Oréal. The collaboration marks the first worldwide large-scale commercialization of Timeline’s proprietary longevity molecule, Mitopure®, within a global skincare brand. For Timeline, this partnership represents the culmination of nearly two decades of scientific research…
Read MoreTune Insight and Softway Medical Partner to Accelerate Medical Research in Europe
Swiss health data technology company and EPFL spinoff Tune Insight has announced a strategic partnership with French digital healthcare leader Softway Medical, marking an important step in the industrial deployment of privacy-preserving data collaboration across Europe. At a time when more than 97% of hospital data remains unused, Tune Insight’s mission is clear: enable health…
Read MoreLimula Enters Commercial Phase of Its Cell Therapy Platform
Vaud-Based biotech company Limula is transitioning from a technology-driven startup to a commercial entity preparing for industrial production and market deployment of LimONE, its cell therapy manufacturing platform. After several years of development, Limula has successfully moved from vision to revenue. In early 2026, Limula engaged with eight biotech companies and clinical centers, generating its…
Read MoreViktor Award 2025: Celebrating Bold Innovation in Swiss Healthcare
The Viktor Award 2025, often referred to as the “Oscar of Swiss Healthcare,” returns for its fifth edition, honoring individuals and institutions that have made a significant impact on Switzerland’s health sector. Nominees are HUG’s project GESICA, Swiss Personalised Health Network, Pink Cube , ART-THERAPY Foundation and the Swiss Cancer Institute. This year, several groundbreaking…
Read More